<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Synthorx, Inc.

    Synthorx, Inc.

    Synthorx is a biotechnology company focused on prolonging and improving the lives ...

    Synthorx is a biotechnology company focused on ...

    Filing Type:    PU
    Halo Cures, Inc.

    Halo Cures, Inc.

    Halo gives scientists and academics opportunities to connect with industry partner...

    Halo gives scientists and academics opportuniti...

    Filing Type:    CF
    ObsEva SA

    ObsEva SA

    Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company foc...

    Founded in November 2012, ObsEva is a clinical-...

    Filing Type:    PU
    Minerva Neurosciences, Inc

    Minerva Neurosciences, Inc

    Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical c...

    Minerva Neurosciences, Inc. (NASDAQ: NERV) is a...

    Filing Type:    PU
    Seelos Therapeutics, Inc.

    Seelos Therapeutics, Inc.

    Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a responsibly-driven company focused o...

    Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a r...

    Filing Type:    PU
    ObsEva SA

    ObsEva SA

    Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company foc...

    Founded in November 2012, ObsEva is a clinical-...

    Filing Type:    PU
    Molecular Templates, Inc.

    Molecular Templates, Inc.

    Molecular Templates is focused on the discovery, development, and commercializatio...

    Molecular Templates is focused on the discovery...

    Filing Type:    PU
    Geron Corporation

    Geron Corporation

    Geron is a late-stage clinical biopharmaceutical company focused on the developmen...

    Geron is a late-stage clinical biopharmaceutica...

    Filing Type:    PU
    Celsion Corporation

    Celsion Corporation

    Celsion Corporation is a fully integrated biopharmaceutical company focused on dev...

    Celsion Corporation is a fully integrated bioph...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.